Please login to the form below

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Herceptin biosimilars can’t make Perjeta cost effective, says NICE. NICE has once again rejected Roche’s HER2-positive breast cancer drug Perjeta for treating patients after surgery in those who ... The Institute had already rejected it in this

ABPI hits out at ‘punitive’ UK medicines pricing plan

Herceptin, MabThera and Humira – but Warwick Smith says the new plan puts this target in jeopardy.

Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar

Will Pfizer spark price war with its Herceptin biosimilar? Eclipsed, but still growing: Opdivo approved in new melanoma setting. ... Tajekesa Chapman, PhD, Pharma Analyst at GlobalData says Herceptin had sales of $2.2bn last year, despite its European

Amgen’s R&D chief Sean Harper retires to seek biotech post

of Amgen’s first biosimilar Kanjinti, a version of Roche’s breast cancer blockbuster Herceptin (trastuzumab).

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Graduate Scientific Editor: DOE

Sudler London - Senior Medical Writer: Competitive

Systematic Review Lead- London: Negotiable

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Associate Scientific Director: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director or Senior Account Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Account Manager – Healthcare Advertising: Salary TBC

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager- 4 days per week or full-time: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....